AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne

PartnershipPositive

AI Analysis

Summary

AOB Pharma and Biorasi partner to conduct a Phase 2b trial in moderate to severe acne, advancing the trial ahead of schedule while maintaining the atopic dermatitis Phase 3 timeline based on encouraging earlier-phase data.

Clinical Trial Data

Phase

Phase 2b

Importance:7/10

Sentiment:

0.60

partnershipPhase 2bacneatopic dermatitisclinical development

Related Companies

$GMRE-PA

Read the original article

Published by PR Newswire Biotech on July 1, 2026 6:37 PM

Read Original